In this project Dr. Ros Quinlivan at University College London will lead an international clinical trial to test, for the first time, the safety and effectiveness of a drug (Sodium Valproate) for McArdle disease. Work carried out in animal models suggests the drug may have a beneficial effect for people with this condition.
